Improved genetic screening for embryos in IVF
Part of Women’s health & pregnancy clinical trials.
This study tests an upgraded genetic test (PGT-A) that checks embryos for extra or missing chromosomes before transfer, which may improve the chance of a successful pregnancy. It is for people doing IVF who face challenges like older age, repeated failures, or miscarriages.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 35 or older, have had repeated failed IVF attempts, have had repeated miscarriages, or the male partner has a severe sperm problem.
- You have at least one embryo that has reached the blastocyst stage (about 5-6 days after fertilization).
- You are not planning to use eggs or sperm from a donor.
- You do not have an untreated uterine shape problem or fluid in the fallopian tubes.
- You are not using this test for chromosomal structural issues or single-gene diseases.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is for women aged 35–40 doing IVF. It compares genetic testing of embryos before transfer to standard care, to see if it improves pregnancy success.
This trial tests whether checking embryos for extra or missing chromosomes (aneuploidy) before transfer improves IVF success for women aged 37-41. You may be eligible if you have a partner or are using donor sperm and have normal ovarian reserve.
This study looks at using embryo genetic testing before pregnancy in IVF for women aged 35 to 40. It may help by identifying which embryos are more likely to lead to a healthy pregnancy, though you would still be screened to confirm you fit the criteria.
This study tests embryos before pregnancy using genetic screening to look for extra or missing chromosomes, in people who have had repeated IVF embryo transfers without success. It may help reduce the chance of transferring embryos that are unlikely to result in a healthy pregnancy.
This study tests a new non-invasive way to check how embryos are developing before they are frozen and later transferred. It looks at fluid around the embryo to see if it can give extra information about embryo health.
This Phase 3 study tests whether growth hormone given during IVF can improve the chance of getting embryos with the “right” number of chromosomes, which is checked by PGT-A. It may help some people who are 38 or older planning chromosome testing of embryos.
Hear when a new Infertility Assisted Reproductive Technology trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.